Patent Assignment
Reel/Frame 031288/0151
Confirmatory License
Recorded: 2013-09-17
Pages: 2
Assignor
THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
Executed: 2013-09-16
Assignee
NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
NIH DIVISION OF EXTRAMURAL INVENTIONS AND TECHNOLOGY RESOURCES (DEITR), 6705 ROCKLEDGE DRIVE, SUITE 310, MSC 7980, BETHESDA, MARYLAND, 20892-7980
Covered Property
(1)
Selective Beta-Glucuronidase Inhibitors as a Treatment for Side Effects of Camptothecin Antineoplastic Agents
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 30, 2012
From: REDINBO, MATTHEW R.; WALLACE, BRET DAVID; LANE, KIMBERLY TERRY
To: THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
Reel/Frame 028876/0684 →
Assignment of Assignor's Interest
Aug 30, 2012
From: WILLIAMS, ALFRED; SCOTT, JOHN; YEH, LI-AN
To: NORTH CAROLINA CENTRAL UNIVERSITY
Reel/Frame 028876/0721 →
Assignment of Assignor's Interest
Aug 30, 2012
From: MANI, SRIDHAR
To: ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY
Reel/Frame 028876/0735 →
Assignment of Assignor's Interest
Oct 16, 2015
From: ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY
To: COM AFFILIATION, INC.
Reel/Frame 036876/0363 →
Change of Name
Oct 20, 2015
From: COM AFFILIATION, INC.
To: ALBERT EINSTEIN COLLEGE OF MEDICINE, INC.
Reel/Frame 036907/0536 →